Vanda Pharmaceuticals Inc.
USD5.48
+0.16 (+3.01%)
CEO
Mihael H. Polymeropoulos
IPO Date
2006-04-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.30
Prev. Close
$5.32
Day Low
$5.28
Day High
$5.50
52W Low
$4.14
52W High
$9.94
Market Cap
$0.33B
Volume
0.71M
| -14.7 |
| 31 Dec 2023 | FY | 92.3% | 1.3% | 0.5% | 0.4% | 0.02 | 4.94 | 96.5 |
| 31 Dec 2022 | FY | 90.5% | 2.5% | 1.2% | 1.0% | 0.02 | 5.68 | 66.5 |
| 31 Dec 2021 | FY | 90.5% | 12.3% | 6.6% | 5.6% | 0.02 | 6.43 | 26.3 |
| 31 Dec 2020 | FY | 90.6% | 9.4% | 5.1% | 4.4% | 0.03 | 6.21 | 30.6 |
| 31 Dec 2019 | FY | 89.2% | 50.9% | 28.1% | 23.9% | 0.04 | 5.95 | 7.5 |
| 31 Dec 2018 | FY | 89.4% | 13.1% | 9.2% | 7.6% | 0.00 | 5.64 | 52.7 |
| 31 Dec 2017 | FY | 89.2% | -9.4% | -11.8% | -7.6% | 0.00 | 2.41 | -43.4 |
| 31 Dec 2016 | FY | 83.1% | -12.3% | -13.7% | -8.6% | 0.00 | 3.46 | -38.5 |
| -0.9 |
| 30 Sept 2025 | Q3 | 94.7% | -40.1% | -4.8% | -3.8% | 0.02 | 3.12 | -3.3 |
| 30 Jun 2025 | Q2 | 91.5% | -51.7% | -5.6% | -4.4% | 0.02 | 3.25 | -2.6 |
| 31 Mar 2025 | Q1 | 93.0% | -58.9% | -5.8% | -4.7% | 0.02 | 3.93 | -2.3 |
| 31 Dec 2024 | Q4 | 95.1% | -9.2% | -0.9% | -0.7% | 0.02 | 4.39 | -14.2 |
| 30 Sept 2024 | Q3 | 94.6% | -11.2% | -1.0% | -0.8% | 0.01 | 4.85 | -12.8 |
| 30 Jun 2024 | Q2 | 91.1% | -9.0% | -0.8% | -0.7% | 0.02 | 4.68 | -18.0 |
| 31 Mar 2024 | Q1 | 88.5% | -8.7% | -0.8% | -0.6% | 0.02 | 4.71 | -14.3 |
| 31 Dec 2023 | Q4 | 92.4% | -5.3% | -0.4% | -0.4% | 0.02 | 4.94 | -25.3 |